Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Similar Companies1000
Comanche Biopharma
Comanche develops siRNA molecules to treat preeclampsia and improve pregnancy outcomes.
Sector
Subsector
Keywords
Location
total rounds
total raised
Biocompatibles
UK-based biotherapeutics company developing products for the treatment of liver and HCC cancer.
Sector
Subsector
Location
Vitaeris
Vitaeris is a biopharmaceutical company developing a monoclonal antibody for the treatment of chronic inflammatory diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Oncurious
Oncurious NV is a Belgium-based biotech company developing innovative oncology treatments.
Sector
Subsector
Location
total rounds
total raised
M&A Details1
Transaction name
Acquired by
Teva Pharmaceutical Industries
announced date
price
Financials
Funding Rounds2
Number of Funding Rounds
Money Raised
Their latest funding was raised on 03.01.2013. Their latest investor Sofinnova Investments. Their latest round Series A
venBio Partners
venBio is a life sciences investment firm that partners with industry leaders to develop groundbreaking medicines.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Sofinnova Investments
Sofinnova Investments is a venture capital firm that specializes in funding and supporting Life Science and Technology start-ups.
Sector
Subsector
Location
count Of Investments
count Of Exists
Canaan Partners
Canaan Partners is an early stage venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
InterWest Partners
InterWest is a venture capital firm that invests in healthcare and IT companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors4
Number of lead investors
Number of investors
Sofinnova Investments
Sofinnova Investments is a venture capital firm that specializes in funding and supporting Life Science and Technology start-ups.
Sector
Subsector
Location
count Of Investments
count Of Exists
Canaan Partners
Canaan Partners is an early stage venture capital firm.
Sector
Subsector
Location
count Of Investments
count Of Exists
Wende Hutton
current job
count Of Investments
InterWest Partners
InterWest is a venture capital firm that invests in healthcare and IT companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Nina Kjellson
General Partner at Canaan & Board Member at Essential Access Health.
current job
People
Founders1
Corey Goodman
Corey Goodman is a renowned scientist, entrepreneur, educator, CEO, and corporate executive. Goodman is Founding Partner of venBio, Adjunct Professor at the University of California, San Francisco, and Chair of the Board of Directors of Limerick BioPharma, Second Genome, Oligasis, and Ossianix, and member of the Board of NeuroTherapeutics Pharma. He is an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Philosophical Society. Goodman was previously President of Pfizer's Biotherapeutics and Bioinnovation Center and a member of its Executive Leadership Team. He is a co-founder of Exelixis, Renovis, and Second Genome, and served as CEO of Renovis prior to its acquisition. Goodman is also a member of the California Council on Science and Technology, the Pacific Institute, the Board of the McKnight Endowment Fund for Neuroscience, BayBio, Biotechnology Institute, Bay Area Science and Innovation Consortium, New York Stem Cell Foundation, QB3 (UCSF-UCB-UCSC) Industry Advisory Board, Stanford's BioX Biosciences Advisory Council, Spinal Muscular Atrophy Foundation, and is former Chair of the National Research Council's Board on Life Sciences. During his academic career, Goodman spent over two decades as a professor of biology and neuroscience at Stanford and U.C. Berkeley, and earning numerous scientific awards such as the Alan T. Waterman Award from the National Science Board, the Gairdner International Award for Achievement in Medical Sciences, and the March-of-Dimes Prize in Developmental Biology. Goodman received his B.S. from Stanford University, Ph.D. from U.C. Berkeley, and was a postdoctoral fellow at U.C. San Diego.
current job
count Of Investments
Corey Goodman